Cita APA (7a ed.)

John Yeakel, M., Aarthi Kannan, B., Nicole Hook Rattigan, P., Maki Yamamoto, M., Alexey Aleshin, M., Jeremy P. Harris, M., MD, & Ling Gao, M. (2021). Bespoke circulating tumor DNA as a biomarker for treatment response in a refractory Merkel cell carcinoma patient. Elsevier.

Cita Chicago Style (17a ed.)

John Yeakel, MD, BA Aarthi Kannan, PhD Nicole Hook Rattigan, MD Maki Yamamoto, MD Alexey Aleshin, MPhil Jeremy P. Harris, MD, y MD Ling Gao. Bespoke Circulating Tumor DNA as a Biomarker for Treatment Response in a Refractory Merkel Cell Carcinoma Patient. Elsevier, 2021.

Cita MLA (8a ed.)

John Yeakel, MD, et al. Bespoke Circulating Tumor DNA as a Biomarker for Treatment Response in a Refractory Merkel Cell Carcinoma Patient. Elsevier, 2021.